ENSRI vs ARCLK Comparison
Price, market cap, valuation, profitability and leverage metrics of ENSRI and ARCLK side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | ENSRI | ARCLK | Sector median |
|---|---|---|---|
| Last price (TL) | 3.13 | 85.25 | 9.29 |
| Daily change | −3.99% | −0.64% | −3.83% |
| Market cap | TRY 1.7B | TRY 57.6B | TRY 2.4B |
| P/B | 1.10 | 0.75 | 0.90 |
| Dividend yield | — | 1.71% | 2.75% |
| Return on equity | −5.60% | −4.06% | 0.38% |
| Free float | 46.10% | 17.46% | 33.00% |
Popular comparisons
Related pages
About the ENSRI vs ARCLK comparison
Price, market cap, valuation multiples, profitability and leverage of ENSRI (Ensari Sinai Yatirimlar) and ARCLK (Arçelik) side by side as of Sep 28, 2026, 12:21. Of the 15 metrics compared, ENSRI leads in 3 and ARCLK leads in 12.
Highlights: Daily change: ARCLK leads (−0.64% vs −3.99%). Market cap: ARCLK leads (TRY 57.6B vs TRY 1.7B). P/B: ARCLK leads (0.75 vs 1.10). EV/EBITDA: ARCLK leads (9.31 vs 68.64). EV/Sales: ARCLK leads (0.90 vs 7.16). Gross margin: ARCLK leads (29.57% vs 10.21%). EBITDA margin (annual): ARCLK leads (14.15% vs 8.61%). Net margin (annual): ARCLK leads (−0.60% vs −18.94%).
Frequently asked questions
Is ENSRI or ARCLK cheaper?
By P/E, Tie is cheaper (— vs —); by P/B, ARCLK trades at the lower multiple (1.10 vs 0.75).
Which is more profitable, ENSRI or ARCLK?
Annual net margin is −18.94% for ENSRI and −0.60% for ARCLK; return on equity is −5.60% for ENSRI and −4.06% for ARCLK.
Which is more leveraged, ENSRI or ARCLK?
The leverage ratio is 39.33 for ENSRI and 86.30 for ARCLK; net debt/EBITDA is 10.55 for ENSRI and 2.78 for ARCLK. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.